Briacell Therapeutics Corp (BCTX)

$2.15 0.01 (0.57%)

15:57 EDT BCTX Stock Quote Delayed 30 Minutes

BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024

By InvestorPlace Earnings Mar 19, 2024

BriaCell Therapeutics just reported results for the second quarter of 2024.

Get Rich Quick With These 3 Penny Stocks to Buy Now

Why Is BriaCell (BCTX) Stock Moving Today?

Short Squeeze Stocks: PROG, SAVA and 3 Others Experts Think Are Ready to Pop

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 8,449

Day's Range $2.13 - $2.35

52-Week Range $2.02 - $7.67

Dividend & Yield N/A (N/A)

BCTX Stock Predictions, Articles, and Briacell Therapeutics Corp News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Aug 18, 2021

Good morning, trader! We're halfway through the week but still going strong with a peek at the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jun 17, 2021

We're starting off the day with a look at the biggest pre-market stock movers for Thursday and it includes loads of medical stocks.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Monday Morning

By Robert Lakin, InvestorPlace Contributor Apr 12, 2021

Get ready for the trading week by diving into today's biggest pre-market movers. Here are the top gainers and losers on Monday morning.

BriaCell shares rise on strong data from breast cancer treatment study (NASDAQ:BCTX)

From Seeking Alpha Feb 7, 2024

BriaCell Therapeutics (BCTX) shares rise 8% premarket after positive data from a mid-stage study of advanced breast cancer patients.

Moleculin investigating possible illegal trading of its shares (NASDAQ:MBRX)

From Seeking Alpha Aug 7, 2023

Moleculin (MBRX) said that it has retained analytics firm Shareholder Intelligence Services, or ShareIntel, to investigate possible naked short selling of its shares. Read more here.

BriaCell to spin out BriaPro Therapeutics (NASDAQ:BCTX)

From Seeking Alpha May 25, 2023

A clinical-stage biotechnology company specialising in targeted immunotherapies for cancer, BriaCell Therapeutics (BCTX) enters into an agreement with BriaPro Therapeutics, a...

BriaCell plans spin-out of pre-clinical assets into new entity (BCTX)

From Seeking Alpha Mar 30, 2023

BriaCell Therapeutics (BCTX) is planning to spin-out certain pre-clinical assets to an unlisted corporation. Read more here

BCTX gains on plans for legal action against illegal stock trading (NASDAQ:BCTX)

From Seeking Alpha Jan 23, 2023

Canadian biotech BriaCell Therapeutics (BCTX) announced Monday that it approved plans to address the alleged illegal stock trading activity, including legal action. Read the full story.

BriaCell to get US, Australian patent linked to personalized cancer immunotherapy

From Seeking Alpha Jan 10, 2023

BriaCell Therapeutics (BCTX) stock rose ~6% on Tuesday after the company said it will get a patent from the U.S

ADVERTISEMENT